The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.
FDA panel recommends Pfizer vaccine for children ages 5 to 11 : Read more
FDA panel recommends Pfizer vaccine for children ages 5 to 11 : Read more